{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-014841","form_type":"8-K","ticker":"FOXO","cik":"0001812360","company_name":"FOXO TECHNOLOGIES INC.","filed_at":"2026-04-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.967586+00:00","generated_at":"2026-05-15T07:52:06.131871+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"confidence":"high","headline":"FOXO Technologies majority stockholder approves authorized share increase from 10B to 25B","bullets":["Majority stockholder (Rennova Health, Inc., controlled by CEO) holding 97.59% voting rights approved via written consent on March 27, 2026.","Amendment increases authorized Class A Common Stock from 10,000,000,000 to 25,000,000,000 shares.","Effective date will be 20 days after mailing of definitive Information Statement; preliminary 14C filed April 1, 2026.","Board has discretion to set effective date without further stockholder approval.","Record date for consent was March 20, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-014841","json":"https://secwatch.observer/filing/0001493152-26-014841.json","markdown":"https://secwatch.observer/filing/0001493152-26-014841.md","text":"https://secwatch.observer/filing/0001493152-26-014841.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1812360/000149315226014841/0001493152-26-014841-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1812360/000149315226014841/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T07:52:06.131871+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}